• Skip to primary navigation
  • Skip to main content
  • Skip to footer
Show Search
Home
EN / FR
  • LinkedIn
  • Twitter
  • YouTube
Celyad Oncology

Celyad Oncology

  • About Us
    • Overview
    • Management Team
    • Board Of Directors
    • Scientific Advisory Board
    • Partners
  • Science
    • Overview
    • Approach
    • Technology
      • TIM
      • shRNA
    • Manufacturing
    • Scientific Publications
  • Pipeline
  • Newsroom
    • Press Releases
    • Events
  • Investors
    • Overview
    • Analyst Coverage
    • Corporate Governance
    • Regulated Information
    • Shareholders Information
    • Shareholders Meeting
  • Contact Us
    • Careers
Home / Investors

Investors

Investors

Corporate Profile

Celyad Oncology is a clinical-stage biotechnology company focused on the discovery and development of chimeric antigen receptor T cell (CAR T) therapies for cancer. The Company is developing a pipeline of allogeneic and autologous CAR T cell therapy candidates for the treatment of both hematological malignancies and solid tumors.

Stock Information
ISIN: BE0974260896-XBRU Updated at
EURONEXT NASDAQ
See Price Chart

Investors Kit

Corporate Presentation

Chairman's Letter 2020

Annual Report 2019

Upcoming Events

Sorry, no posts matched your criteria.

See More Events

Latest Financial News

7

May
2020

First Quarter 2020 Financial Results and Recent Business Highlights

22

Mar
2020

Annual Report 2019

19

Nov
2019

Celyad Announces Third Quarter 2019 Financial Results and Recent Business Highlights

discover all Financial News

Financial Calendar

May 7, 2020

Q1 2020 Financial Results

Aug 6, 2020

H1 2020 Financial Results

Sep 28, 2020

R&D Day at Nasdaq

Nov 10, 2020

Q3 2020 Financial Results

Footer

  • About
  • Science
  • Pipeline
  • Investors
  • Contact Us
  • LinkedIn
  • Twitter
  • YouTube

Copyright © 2020 All Rights Reserved.
Cookie Policy | Privacy Policy | Terms of Use

Our website uses cookies including analytics cookies to help us improve it by collecting statistics on how visitors use our website. By clicking on “I accept”, you allow us to place these analytics cookies. We also use cookies that are necessary for the good-functioning of our website. You can find more information about the cookies we use by visiting our Cookie Policy.I AcceptI RefuseCookie Policy